Collects and standardizes real-world clinical data from diverse EHR systems into a unified, structured format.
Transforms clinical data into actionable insights for research, regulatory submissions, and healthcare decisions.
Supports patient identification, site selection, and trial design using real-world data to accelerate timelines.
Provides advanced tools for querying, visualizing, and interpreting oncology data with customizable reports.
Ensures data privacy, security, and adherence to healthcare regulations such as HIPAA and GDPR.
Facilitates data sharing and multi-institutional collaboration for oncology studies and consortia.
Use real-world data to identify patient populations, optimize clinical trial designs, and support regulatory submissions for new oncology therapies.
Leverage data insights to find eligible patients more efficiently, reducing recruitment times and enhancing trial success rates.
Analyze treatment patterns and outcomes to inform evidence-based care decisions and personalize cancer therapies.
Generate evidence on cost-effectiveness, treatment value, and market access strategies for oncology products.
Track adverse events and safety profiles in real-world settings to ensure patient safety and regulatory compliance.
Use data-driven insights to tailor treatments based on individual patient characteristics, improving efficacy and reducing side effects.
Help oncology practices streamline workflows, improve quality of care, and enhance operational efficiency through data analytics.
Provide access to high-quality data for epidemiological studies, clinical research projects, and peer-reviewed publications.
Prepare and submit real-world evidence to regulatory agencies like the FDA for drug approvals and label expansions.
Create comprehensive databases for long-term cancer surveillance, population health management, and public health initiatives.
Sign in to leave a review
Activ Surgical is an innovative medical technology company that develops intelligent surgical systems designed to enhance precision and outcomes in various surgical procedures. Their platform leverages artificial intelligence (AI), augmented reality (AR), and computer vision to provide real-time visualization and data-driven guidance during surgeries. Aimed at improving patient safety and reducing complications, the technology integrates seamlessly with existing surgical equipment, such as endoscopes and imaging systems, to overlay critical anatomical information and optimize surgical paths. This assists surgeons in making informed decisions, particularly in minimally invasive and complex open surgeries. By digitizing surgical processes, Activ Surgical contributes to the advancement of surgical care through enhanced efficiency, accuracy, and training capabilities. The system is adaptable across multiple surgical specialties, supporting a future where AI-driven tools become standard in operating rooms for better healthcare delivery.
BenevolentAI is a technology company that leverages artificial intelligence to accelerate and enhance drug discovery and development processes. By integrating vast biomedical datasets with advanced machine learning algorithms, the platform enables researchers to identify novel drug targets, predict drug efficacy and safety, optimize clinical trial designs, and repurpose existing drugs for new indications. Focused on addressing diseases with high unmet medical needs, such as cancer and neurological disorders, BenevolentAI aims to transform the pharmaceutical industry by reducing the time, cost, and failure rates associated with bringing new therapies to market. The platform combines AI-driven insights with domain expertise, providing a collaborative environment for scientists to generate hypotheses, validate candidates, and streamline decision-making in research pipelines. Its comprehensive approach includes data analysis, predictive modeling, and integration with existing laboratory systems, making it a powerful tool for biotech and pharma companies seeking innovation in drug development.
Biofourmis is a pioneering digital health company that specializes in AI-driven remote patient monitoring and personalized care solutions. Their flagship platform, Biovitals, leverages advanced machine learning algorithms to analyze continuous physiological data collected from wearable sensors. This enables healthcare providers to monitor patients in real-time, detect early signs of health deteriorations, and intervene proactively. The platform is designed to manage a wide range of clinical conditions, including chronic heart failure, diabetes, hypertension, and post-operative recovery. By integrating seamlessly with electronic medical record systems, Biofourmis facilitates efficient data flow and enhances clinical decision-making. The company serves various stakeholders, from large hospital systems to pharmaceutical companies conducting decentralized clinical trials. Biofourmis aims to improve patient outcomes, reduce hospital readmissions, and lower healthcare costs through data-driven insights. Their technology is scalable, secure, and compliant with global healthcare regulations, making it a trusted partner in transforming care delivery. With a focus on innovation, Biofourmis continues to expand its capabilities, offering tools for predictive analytics, personalized treatment plans, and population health management.
